Delayed-Release Multi Matrix System (MMX™) Mesalazine: In Ulcerative Colitis

Author： McCormack Paul L.   Robinson Dean M.   Perry Caroline M.  

Publisher： Adis International

ISSN： 0012-6667

Source： Drugs, Vol.67, Iss.17, 2007-01, pp. : 2635-2642

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Delayed-Release Multi Matrix System (MMX™) Mesalazine in Ulcerative Colitis: A Viewpoint by Åke Nilsson

By Nilsson Åke  

Drugs, Vol. 67, Iss. 17, 2007-01 ,pp. : 2643-2644

Adis International

Access to resources Recommend Favorite

Delayed-release MMX™ mesalazine: a guide to its use in ulcerative colitis

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 24, Iss. 5, 2008-05 ,pp. : 6-8

Adis International

Access to resources Recommend Favorite

Multi-Matrix System (MMX®) mesalamine for the treatment of mild-to-moderate ulcerative colitis

By Horst Sara N   Kane Sunanda  

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 15, 2012-10 ,pp. : 2225-2232

Informa Healthcare

Access to resources Recommend Favorite

Oral Delayed-Release Mesalazine: A Review of its Use in Ulcerative Colitis and Crohn's Disease

By Prakash A.   Markham A.  

Drugs, Vol. 57, Iss. 3, 1999-03 ,pp. : 383-408

Adis International

Access to resources Recommend Favorite

MMX makes the most of mesalazine in ulcerative colitis

By  

Inpharma, Vol. 1, Iss. 1565, 2006-01 ,pp. : 13-14

Adis International

Access to resources Recommend Favorite